Layton Mills and Margaret Curtis agreed to acquire 52% stake in CannPal Animal Therapeutics Limited from AusCann Group Holdings Ltd (ASX:AC8) for AUD1 on March 10, 2023. AusCann also retains the right to re-acquire the shares in CannPal for nominal consideration AUD1 upon the failure of the SPV to fund and complete the agreed development and commercialisation milestones. The SSA contains a sunset date of March 31, 2023.
CannPal Animal Therapeutics Limited
Equities
CP1
AU000000CP17
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-1.47% | 103B | |
+9.04% | 101B | |
+4.40% | 23.07B | |
-12.18% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.23% | 16.94B | |
+6.84% | 14.07B | |
+38.66% | 12.35B |